Sorry, been in hibernation, but doesn't Ori/Hepalink have representation on the RVX Board? I thought 1 or 2 members had strong connections back to them, but I may be mis-remembering (or hallucinating).

Blows me away that we have several "whale" investors on board (albeit in the red), with a drug so close and with some very impressive credentials, ... and yet NONE of those very wealthy "RVX stakeholders" have dropped another wooden nickel. On a drug that could give them a many fold ROI. But those are smart people also. Fool me once? No more good money after bad money?

Most of them are in around $2.60 or lower right? ... wonder if they would just like to get their money back out, for say $3? ... or, if they are still firmly excited about the science enough to wait it out (like the rest of us) on a rudderless boat until help arrives since they won't reopen their cookie jar?

Yeahhhhh ... I would L-O-V-E to know what of some of my other bigger but fellow investors like Ori, Eastern, Hepalink, etc are being told. Especially Hepa, given so many current issues & opportunities with them specifically (debenture/IP) - at least Hepa has stepped up and pledged financial support for BoM2 though.